28 Oct 2022 , 05:30 PM
Net profit of Astec Lifesciences rose 101.87% to Rs 18.31 crore in the quarter ended September 2022 as against Rs 9.07 crore during the previous quarter ended September 2021. Sales rose 94.75% to Rs 199.75 crore in the quarter ended September 2022 as against Rs 102.57 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 199.75 | 102.57 | 95 |
| OPM % | 16.66 | 20.55 | – |
| PBDT | 32.75 | 20.33 | 61 |
| PBT | 24.58 | 12.18 | 102 |
| NP | 18.31 | 9.07 | 102 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
